Recent practice advancements, scientific discoveries, product development and manufacturing are the topics featured at the 2018 Mayo Clinic Symposium on Regenerative Medicine and Surgery. Regenerative medicine leaders from around the globe will come together Nov. 29 – Dec. 1 at the Westin Kierland Resort in Scottsdale, AZ. This year’s symposium will emphasize clinical trial breakthroughs and therapeutic interventions that address diseases and conditions such as cancer, Alzheimer’s disease, spinal-cord injuries and diabetes. Updates on product development and manufacturing, CAR-T cell therapy, and the first patients treated at the Florida Regenerative Medicine Therapeutic Suites will also be presented.
“The symposium is a forum for the regenerative medicine community to engage and learn how science driven practice advancements in regenerative medicine are increasingly embedded in daily practice,” says Andre Terzic, M.D., Ph.D., the Michael S. and Mary Sue Shannon Family Director, Center for Regenerative Medicine, and the Marriott Family Director, Comprehensive Cardiac Regenerative Medicine. “We’re looking forward to hosting the growing regenerative medicine community to share experiences in bringing regenerative medicine breakthroughs to clinical trials and practice applications addressing patient needs.”
Hear from keynote speakers on trends in clinical application, discovery science, regulatory science, cGMP manufacturing and quality assurance, and clinical trials. Sessions planned for the three-day symposium include:
- Regenerative Medicine Breakthroughs
- Intervention Spotlight
- Clinical Trials & Clinical Experience
- Regenerative Discoveries
- Future of Regenerative Medicine
- Accelerating Therapies to Application
- Enterprise Translational Capabilities
- Interactive Training and Education sessions
Richard McFarland, M.D., Ph.D., chief regulatory officer at Biofab, will share best practices in industry partnerships to accelerate regenerative therapies into patient care. Peter Marinkovich, M.D., associate professor of Dermatology at Stanford University, will present the progress of skin regeneration in patients with Epidermolysis Bullosa, a genetic skin disease.
“Drs. McFarland and Marinkovich are renowned in the field of regenerative medicine, and we’re excited to have them present at the symposium,” says Richard Hayden, M.D., an otolaryngologist and director of education for the Center for Regenerative Medicine. “Additionally, the CAR-T cell therapy update and interactive education sessions will be highlights of the symposium.”
The symposium is open to everyone, including clinicians, researchers, educators, students, industry and the general public. Early registration discounts are available through Oct. 15 and student discounts apply.
Learn more about the 2018 Mayo Clinic Symposium on Regenerative Medicine and Surgery on the Center for Regenerative Medicine blog.